331 related articles for article (PubMed ID: 29559287)
21. High-dose-rate interstitial computed tomography-based brachytherapy for the treatment of cervical cancer: early results.
Kannan N; Beriwal S; Kim H; Houser C; Mogus R; Sukumvanich P; Olawaiye AB; Richard S; Kelley JL; Edwards RP; Krivak TC
Brachytherapy; 2012; 11(5):408-12. PubMed ID: 22513106
[TBL] [Abstract][Full Text] [Related]
22. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
[TBL] [Abstract][Full Text] [Related]
23. Concordance of FDG PET/CT metabolic tumour volume versus DW-MRI functional tumour volume with T2-weighted anatomical tumour volume in cervical cancer.
Lai AYT; Perucho JAU; Xu X; Hui ES; Lee EYP
BMC Cancer; 2017 Dec; 17(1):825. PubMed ID: 29207964
[TBL] [Abstract][Full Text] [Related]
24. A 3-year follow-up study of radiotherapy using computed tomography-based image-guided brachytherapy for cervical cancer.
Kawashima A; Isohashi F; Mabuchi S; Sawada K; Ueda Y; Kobayashi E; Matsumoto Y; Otani K; Tamari K; Seo Y; Suzuki O; Sumida I; Tomimatsu T; Kimura T; Ogawa K
J Radiat Res; 2019 Mar; 60(2):264-269. PubMed ID: 30649485
[TBL] [Abstract][Full Text] [Related]
25. Diffusion-weighted MRI in image-guided adaptive brachytherapy: Tumor delineation feasibility study and comparison with GEC-ESTRO guidelines.
Schernberg A; Balleyguier C; Dumas I; Gouy S; Escande A; Bentivegna E; Morice P; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2017; 16(5):956-963. PubMed ID: 28673762
[TBL] [Abstract][Full Text] [Related]
26. Positron emission tomography for staging locally advanced cervical cancer and assessing intensity modulated radiotherapy approach.
Draghini L; Costantini S; Vicenzi L; Italiani M; Loreti F; Trippa F; Arcidiacono F; Casale M; Mantello G; Maranzano E
Radiol Med; 2019 Sep; 124(9):819-825. PubMed ID: 30904982
[TBL] [Abstract][Full Text] [Related]
27. Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing
Barabasch A; Heinzel A; Bruners P; Kraemer NA; Kuhl CK
Radiology; 2018 Sep; 288(3):764-773. PubMed ID: 29786487
[TBL] [Abstract][Full Text] [Related]
28. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
[TBL] [Abstract][Full Text] [Related]
29. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
30. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract][Full Text] [Related]
31. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
[TBL] [Abstract][Full Text] [Related]
32. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Chung YL; Horng CF; Lee PI; Chen FL
BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
[TBL] [Abstract][Full Text] [Related]
33. Combined pretreatment with
Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
[TBL] [Abstract][Full Text] [Related]
34. Impact on treatment time of MRI-based brachytherapy in two implants (4 doses) compared with CT-based brachytherapy in five implants for cervical cancer.
Small C; Harmon G; Weaver J; Vivirito V; Durazo-Arvizu R; Small W; Harkenrider MM
Brachytherapy; 2019; 18(2):141-145. PubMed ID: 30497938
[TBL] [Abstract][Full Text] [Related]
35. Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.
Schuetz M; Schmid MP; Pötter R; Kommata S; Georg D; Lukic D; Dudczak R; Kletter K; Dimopoulos J; Karanikas G; Bachtiary B
Acta Oncol; 2010 Oct; 49(7):941-7. PubMed ID: 20831481
[TBL] [Abstract][Full Text] [Related]
36. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
[TBL] [Abstract][Full Text] [Related]
37. Outcomes analysis of pre-brachytherapy MRI in patients with locally advanced cervical cancer.
Murofushi K; Yoshioka Y; Sumi M; Ishikawa H; Oguchi M; Sakurai H
Int J Gynecol Cancer; 2020 Apr; 30(4):473-479. PubMed ID: 32165406
[TBL] [Abstract][Full Text] [Related]
38. HIV status does not have an impact on positron emission tomography-computed tomography (PET-CT) findings or radiotherapy treatment recommendations in patients with locally advanced cervical cancer.
Simonds H; Botha MH; Ellmann A; Warwick J; Doruyter A; Neugut AI; Van Der Merwe H; Jacobson JS
Int J Gynecol Cancer; 2019 Oct; 29(8):1252-1257. PubMed ID: 31413068
[TBL] [Abstract][Full Text] [Related]
39. Point-Based Brachytherapy in Cervical Cancer With Limited Residual Disease: A Low- and Middle-Income Country Experience in the Era of Magnetic Resonance-Guided Adaptive Brachytherapy.
Gupta A; Dey T; Rai B; Oinam AS; Gy S; Ghoshal S
JCO Glob Oncol; 2021 Sep; 7():1602-1609. PubMed ID: 34843375
[TBL] [Abstract][Full Text] [Related]
40. Comparison of positron emission tomography/computed tomography and magnetic resonance imaging for posttherapy evaluation in patients with advanced cervical cancer receiving definitive concurrent chemoradiotherapy.
Su TP; Lin G; Huang YT; Liu FY; Wang CC; Chao A; Chou HH; Yen TC; Lai CH
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):727-734. PubMed ID: 29159572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
